Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog and search the HCV drug pipeline click here; for more information on HCV clinical trials click here

Be sure to check out our other blog: Hepatitis & Tattoos

Alan Franciscus
Editor-in-Chief
HCV Advocate
HBV Advocate

Friday, January 25, 2013

Treatment response improved neurocognitive function in patients with chronic HCV

Patients with chronic HCV who responded to treatment with pegylated interferon and ribavirin experienced a subsequent improvement to neurocognitive performance in a recent study.
Using the Test for Attentional Performance (TAP), researchers evaluated the neurocognitive capabilities of 168 adult patients with hepatitis C before and after weekly treatment with peginterferon alfa-2b and weight-based ribavirin for 24 or 48 weeks. Participants took the computer-aided TAP test at baseline and 12 months or longer (range 12 to 48 months) after completing therapy.

 Read more....
Posted by at
Labels: , , ,

2 comments:

  1. This is great news for people to hear! Most people I know have had similar improvements including myself after achieving a viral cure. AF

    ReplyDelete

  2. This is certainly an incentive to pursue treatment

    ReplyDelete

Subscribe to: Post Comments (Atom)